Skip to content
Data Provider: Welsh Government National Statistics Patients newly diagnosed via the urgent suspected cancer route starting treatment by quarter
None
[Collapse]Cancer Site[Filter]
-
Cancer Site 1[Filter]
[Collapse]Trust Name[Filter]
-
[Collapse]Trust Name 1[Filter]
-
Trust Name 2[Filter]
Measure1
Measure[Filter]
Quarter[Filter]
Click here to sortTotal starting treatment within 62 daysClick here to sortTotal starting treatmentClick here to sort% starting treatment within 62 days
Quarter ending Sept 2005Information was not available for:<br />Pembrokeshire and Derwen NHS Trust - Lung and Upper Gastrointestinal cancers.<br />Pontypridd and Rhondda NHS Trust - Upper Gastrointestinal cancer..The data item is not applicable.The data item is not applicable.The data item is not applicable
Quarter ending Dec 2005Information was not available for: <br />Conwy and Denbighshire - Gynaecological or Skin. <br />North Glamorgan - Skin.<br />Pembrokeshire and Derwen NHS Trust - Gynaecological, Lung, Skin, Upper Gastroinestinal or Urological..The data item is not applicable.The data item is not applicable.The data item is not applicable
Quarter ending Mar 2006Information was not available for: <br />North Glamorgan - Head and Neck.<br />Pembrokeshire and Derwen - Gynaecological, Haematological, Head and Neck, Lung, Skin, Upper Gastrointestinal or Urological. <br />Pontypridd and Rhondda - Gynaecological, Haematological, Head and Neck or Skin..The data item is not applicable.The data item is not applicable.The data item is not applicable
Quarter ending Jun 2006Information was not available for: <br />Ceredigion – Brain/CNS<br />Conwy and Denbighshire – Acute Leukaemia, Brain/CNS or Sarcoma <br />North Glamorgan –Acute Leukaemia, Brain/CNS, Head and Neck or Sarcoma.<br />Pembrokeshire and Derwen – Acute Leukaemia, Brain/CNS, Gynaecological, Haematological,  Head and Neck, Lung, Sarcoma, Skin, Upper Gastrointestinal or Urological. <br />Pontypridd and Rhondda - Acute Leukaemia, Brain/CNS, Gynaecological, Haematological, Head and Neck or Skin..The data item is not applicable.The data item is not applicable.The data item is not applicable
Quarter ending Sept 2006Information was not available for:<br />North Glamorgan - Brain/CNS and Children\'s cancer for the quarter and Sarcoma for July only.<br />North West Wales - Children\'s cancer.<br />Pembrokeshire and Derwen for the month of July - Acute Leukaemia, Brain/CNS, Gynaecological, Haematological, Head and Neck, Lung, Sarcoma, Skin, Upper Gastrointestinal, Urological, Children\'s cancer or Other.<br />Pontypridd and Rhondda - Brain/CNS or Children\'s cancer.71197973
Quarter ending Dec 2006Information was not available for:<br />North Glamorgan - Children\'s cancer and Brain/CNS both for October<br />North West Wales - Children\'s cancer7981,05276
Quarter ending Mar 20078891,03886
Quarter ending Jun 20079831,08291
Quarter ending Sept 20071,0571,13693
Quarter ending Dec 20071,0311,10094
Quarter ending Mar 20081,0821,10798
Quarter ending June 20081,0581,09297
Quarter ending Sept 2008Figures for the quarter ending September 2008 are provisional.1,1021,16794
Quarter ending Dec 20081,1701,24594
Quarter ending Mar 20091,1241,20893
Quarter ending Jun 20091,1931,29192
Quarter ending Sept 20091,1441,26391

Metadata

Title

0008 urgent suspected cancer route

Notes 1

The patients shown here are those treated via the urgent route. The national target for these patients is:

Patients referred by their GP with urgent suspected cancer and subsequently diagnosed as such by a cancer specialist will start definitive treatment within 62 days of receipt of referral.

Data are collected for 13 cancer tumour sites and an 'other' category. Results were published only for the sites judged to have data of sufficient quality, with more sites added as quality improved. It should be noted that for many trusts the number of tumour sites reported against has increased each quarter and therefore it is not advisable to make comparisons between quarters. For some cancer tumour sites the total number of patients starting treatment within the quarter is small. Care should be taken when interpreting percentages based on small numbers of patients.



Name

Hlth0008newmeasures